BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6733233)

  • 1. Nonparametric estimation of the distribution of time to onset for specific diseases in survival/sacrifice experiments.
    Turnbull BW; Mitchell TJ
    Biometrics; 1984 Mar; 40(1):41-50. PubMed ID: 6733233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonparametric estimation of lifetime and disease onset distributions from incomplete observations.
    Dinse GE; Lagakos SW
    Biometrics; 1982 Dec; 38(4):921-32. PubMed ID: 7168795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonparametric joint estimators for disease resistance and survival functions in survival/sacrifice experiments.
    Kodell RL; Shaw GW; Johnson AM
    Biometrics; 1982 Mar; 38(1):43-58. PubMed ID: 7082762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Log-linear models in the analysis of disease prevalence data from survival/sacrifice experiments.
    Mitchell TJ; Turnbull BW
    Biometrics; 1979 Mar; 35(1):221-34. PubMed ID: 315241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonparametric methods for survival/sacrifice experiments.
    Dewanji A; Kalbfleisch JD
    Biometrics; 1986 Jun; 42(2):325-41. PubMed ID: 3741974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-response test via closed-form solutions for constrained MLEs in survival/sacrifice experiments.
    Kim W; Ahn H; Moon H
    Stat Med; 2007 Feb; 26(3):694-708. PubMed ID: 16596576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized tumor rates for chronic bioassays.
    Kodell RL; Gaylor DW; Chen JJ
    Biometrics; 1986 Dec; 42(4):867-73. PubMed ID: 3814727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonparametric estimation of the survival function when cause of death is uncertain.
    Racine-Poon AH; Hoel DG
    Biometrics; 1984 Dec; 40(4):1151-8. PubMed ID: 6534414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An age-adjusted trend test for the tumor incidence rate for multiple-sacrifice experiments.
    Kodell RL; Ahn H
    Biometrics; 1997 Dec; 53(4):1467-74. PubMed ID: 9423261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiparametric estimation in a three-state duration-dependent Markov model from interval-censored observations with application to AIDS data.
    Frydman H
    Biometrics; 1995 Jun; 51(2):502-11. PubMed ID: 7662839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating constraints that allow survival-adjusted incidence analyses in single-sacrifice studies.
    Dinse GE
    Biometrics; 1993 Jun; 49(2):399-407. PubMed ID: 8369376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of associations between diseases in animal carcinogenicity experiments.
    Mitchell TJ; Turnbull BW
    Biometrics; 1990 Jun; 46(2):359-74. PubMed ID: 2364126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constant risk differences in the analysis of animal tumorigenicity data.
    Dinse GE
    Biometrics; 1991 Jun; 47(2):681-700. PubMed ID: 1912267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An illness-death model for the study of the carcinogenic process using survival/sacrifice data.
    Kodell RL; Nelson CJ
    Biometrics; 1980 Jun; 36(2):267-77. PubMed ID: 7407315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of lag time between onset of and death from an occult tumor.
    Ahn H; Moon H; Kodell RL
    J Biopharm Stat; 2008; 18(5):901-14. PubMed ID: 18781524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for assessing age-time disease incidence using serial prevalence data.
    Marschner IC
    Biometrics; 1997 Dec; 53(4):1384-98. PubMed ID: 9423255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring weighted (IPCW) methods.
    Matsuyama Y; Yamaguchi T
    Pharm Stat; 2008; 7(3):202-14. PubMed ID: 17554753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximum likelihood estimation of ordered multinomial parameters.
    Jewell NP; Kalbfleisch JD
    Biostatistics; 2004 Apr; 5(2):291-306. PubMed ID: 15054032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.